Aimmune Therapeutics Inc buy marge
Start price
20.11.17
/
50%
€31.58
Target price
01.01.19
€36.08
Performance (%)
-31.68%
End price
01.01.19
€21.58
Summary
This prediction ended on 01.01.19 with a price of €21.58. The BUY prediction by marge for Aimmune Therapeutics Inc performed very badly with a performance of -31.68%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aimmune Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
| iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
| iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
| iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
Comments by marge for this prediction
In the thread Aimmune Therapeutics Inc diskutieren
marge stimmt der Outperform-Einschätzung der institutionellen Analysten zu
marge stimmt am 20.11.2017 der Outperform-Einschätzung der institutionellen Analysten zu.
- Aimmune Therapeutics (NASDAQ:AIMT) initiated with Buy rating and $60 (71% upside) price target by Roth Capital.
(Laufzeit überschritten)
Stopped prediction by marge for Aimmune Therapeutics Inc
Aimmune Therapeutics Inc
Start price
Target price
Perf. (%)
€19.28
06.09.19
06.09.19
€30.00
04.11.21
04.11.21
51.45%
05.11.21
05.11.21
